Phosphatidylinositol 3′ Kinase Signaling in Mammary Tumorigenesis

Journal of Mammary Gland Biology and Neoplasia

Volumn 6, Issue 1, 2001, Pages 83-99

  Scheid, Michael P ^a   Woodgett, James R ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Apoptosis; PDK 1; PI3K; PKB Akt; Tumorigenesis

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL; ENZYMOLOGY; EXPERIMENTAL NEOPLASM; FEMALE; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; FEMALE; HUMANS; MAMMARY NEOPLASMS, ANIMAL; SIGNAL TRANSDUCTION;

EID: 0035235458     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009520616247     Document Type: Article

References (157)

1. S. A. Courtneidge and A. Heber (1987). An 81 kd protein complexed with middle T antigen and pp60c-src: A possible phosphatidylinositol kinase. Cell 50:1031-1037.
2. C. P. Whitman, M. Downes, T. Keeler, and L. Cantley (1988). Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature 332:644-646.
3. A. E. Traynor-Kaplan, A. L. Harris, B. L. Thompson, P. Taylor, and L. A. Sklar (1988). An inositol tetrakisphosphate-containing phospholipid in activated neutrophils. Nature 334:353-356.
4. A. Toker and L. C. Cantley (1997). Signaling through the lipid products of phosphoinositide 3-OH kinase. Nature 387:673-676.
5. I. D. Hiles, M. Otsu, S. Volinia, M. J. Fry, I. Gout, R. Dhand, G. Panayotou, F. Ruiz-Larrea, A. Thompson, N. Totty, J. J. Hsuan, S. A. Courtneidge, P. J. Parker, and M. D. Waterfield (1992). Phosphatidylinositol 3-kinase: Structure and expression of the 110 kd catalytic submit. Cell 70:419-429.
6. P Hu, A. Mondino, E. Y. Skolnik, and J. Schlessinger (1993). Cloning of a novel, ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding site on p85. Mol. Cell. Biol. 13:7677-7688.
7. B. Vanhaesebroeck, M. J. Welham, K. Kotani, R. Stein, P. H. Warne, M. J. Zvelebil, K. Higashi, S. Volinia, J. Downward, and M. D. Waterfield (1997). P110δ, a novel phosphoinositide 3-kinase in leukocytes. Proc. Natl. Acad. Sci. U.S.A. 94:4330-4335.
8. L. R. Stephens, A. Eguinoa, H. Erdjument-Bromage, M. Lui, F. Cooke, J. Coadwell, A. S. Smrcka, M. Thelen, K. Cadwallader, P. Tempst, and P. T. Hawkins (1997). The Gβγ sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101. Cell 89:105-114.
9. B. Stoyanov, S. Volinia, T. Hanck, I. Rubio, M. Loubtchenkov, D. Malek, S. Stoyanova, B. Vanhaesenbroeck, R. Dhand, B. Nurnberg, P. Gierschik, K. Seedorf, J. J. Hsuan, M. D. Waterfield, and R. Wetzker (1995). Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science 269:690-693.
10. Z. Songyang, S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider, B. G. Neel, R. B. Birge, J. E. Fajardo, M. M. Chou, H. Hanafusa, B. Schaffhausen, and L. C. Cantley (1993). SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778.
11. J. J. Herbst, G. Andrews, L. Contillo, L. Lamphere, J. Gardner, G. E. Lienhard, and E. M. Gibbs (1994). Potent activation of phosphatidylinositol 3′-kinase by simple phosphotyrosine peptides derived from insulin receptor substrate 1 containing two YMXM motifs for binding SH2 domains. Biochemistry 33:9376-9381.
12. G. B. Cohen, R. Ren, and D. Baltimore (1995). Modular binding domains in signal transduction proteins. Cell 80:237-248.
13. I. Gout, R. Dhand, I. D. Hiles, M. J. Fry, G. Panayatou, P. Das, O. Truong, N. Totty, J. Hsuan, G. W. Booker, I. D. Campbell, and M. D. Waterfield (1993). The GTPase dynamin binds to and is activated by a subset of SH3 domains. Cell 75:25-36.
14. S. Hunter, B. L. Koch, and S. M. Anderson (1997). Phosphorylation of cbl after stimulation of Nb2 cells with prolactin and its association with phosphatidylinositol 3-kinase. Mol. Endocrinol. 11:1213-1222.
15. C. Guinebault, B. Payrastre, C. Racaud-Sultan, H. Mazarguil, M. Breton, G. Mauco, M. Plantavid and H. Chap (1995). Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85 a with actin filaments and focal adhesion kinase. J. Cell Biol. 129:831-842.
16. J. Wang, K. R. Auger, L. Jarvis, Y. Shi, and T. M. Roberts (1995). Direct association of Grb2 with the p85 subunit of phosphatidylinositol 3-kinase. J. Biol. Chem. 270:12774-12782.
17. F. Shibasaki, F. Fukami, Y. Fukui, and T. Takenawa (1994). Phosphatidylinositol 3-kinase binds to α-actinin through the p85 subunit. Biochem. J. 302:551-557.
18. C. M. Pleiman, W. M. Hertz, and J. C. Cambier (1994). Activation of phosphatidylinositol 3′-kinase by Src-family kinase SH3 binding to the p85 subunit. Science 263:1609-1612.
19. V. Stambolic, A. Suzuki, J. L. de la Pompa, G. M. Brothers, C. Mirtsos, T. Sasaki, J. Ruland, J. M. Penninger, D. P. Siderovski, and T. W. Mak (1998). Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29-39.
20. J. E. Damen, L. Liu, P. Rosten, R. K. Humphries, A. B. Jefferson, P. W. Majerus, and G. Krystal (1996). The 145-kDa protein induced to associate with She by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase. Proc. Natl. Acad. Sci. U.S.A. 93:1689-1693.
21. Q. Liu, T. Sasaki, I. Kozieradzki, A. Wakeham, A. Itie, D. J. Dumont, and J. M. Penninger (1999). SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes Dev. 13:786-791.
22. R. J. Haslam, H. B. Koide, and B. A. Hemmings (1993). Pleckstrin domain homology. Nature 363:309-310.
23. B. J. Mayer, R. Ren, K. L. Clark, and D. Baltimore (1993). Aputative modular domain present in diverse signaling proteins. Cell 73:629-630.
24. A. Musacchio, T. Gibson, P. Rice, J. Thompson, and M. Saraste (1993). The PH domain: A common piece in the structural patchwork of signaling proteins. Trends Biochem. Sci. 18:343-348.
25. M. Saraste and M. Hyvonen (1995). Pleckstrin homology domains: A fact file. Curr. Opin. Struct. Biol. 5:403-408.
26. M. J. Macias, A. Musacchio, H. Ponstingl, M. Nilges, M. Saraste, and H. Oschkinat (1994). Structure of the pleckstrin homology domain from β-spectrin. Nature 369:675-677.
27. M. G. Myers, Jr. , T. C. Grammer, J. Brooks, E. M. Glasheen, L. M. Wang, X. J. Sun, J. Blenis, J. H. Pierce, and M. F. White (1995). The pleckstrin homology domain in insulin receptor substrate-1 sensitizes insulin signaling. J. Biol. Chem. 270:11715-11718.
28. K. M. Ferguson, M. A. Lemmon, J. Schlessinger, and P. B. Sigler (1994). Crystal structure at 2. 2 A resolution of the pleckstrin homology domain from human dynamin. Cell 79:199-209.
29. K. Salim, M. J. Bottomley, E. Querfurth, M. J. Zvelebil, I. Gout, R. Scaife, R. L. Margolis, R. Gigg, C. I. Smith, P. C. Driscoll, M. D. Waterfield, and G. Panayotou (1996). Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domain of dynamin and Bruton's tyrosine kinase. EMBO J. 15:6241-6250.
30. J. Wang, K. R. Auger, L. Jarvis, Y. Shi, and T. M. Roberts (1995). Direct association of Grb2 with the p85 subunit of phosphatidylinositol 3-kinase. J. Biol. Chem. 270:12774-12782.
31. 1: Catalytic and membrane binding properties. J. Biol. Chem. 268:11586-11593.
32. A. Gray, J. Van Der Kaay, and C. P. Downes (1999). The pleckstrin homology domains of protein kinase B and GRP1 (general receptor for phosphoinositides-1) are sensitive and selective probes for the cellular detection of phosphatidylinositol 3,4-bisphosphate and/or phosphatidylinositol 3,4,5-trisphosphate in vivo. Biochem. J. 344:929-936.
33. N. E. Hynes and D. F. Stern (1994). The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim. Biophys. Acta. 1198:165-184.
34. K. L. Troyer and D. C. Lee (2001). Regulation of mouse gland development and tumorgenesis by the ERBB signaling network. J. Mam. Gland Biol. Neoplasia 6(1):7-21.
35. M. Yoakim, W. Hou, Z. Songyang, Y. Liu, L. Cantley, and B. Schaffhausen (1994). Genetic analysis of a phosphatidylinositol 3-kinase SH2 domain reveals determinants of specificity. Mol. Cell. Biol. 14:5929-5938.
36. L. Sepp-Lorenzino, I. Eberhard, Z. Ma, C. Cho, H. Serve, F. Liu, N. Rosen, and R. Lupu (1996). Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells. Oncogene 12:1679-1687.
37. W. J. Muller, E. Sinn, P. K. Pattengale, R. Wallace, and P. Leder (1988). Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54:105-115.
38. K. L. Carraway, 3rd, S. P. Soltoff, A. J. Diamonti, and L. C. Cantley (1995). Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3. J. Biol. Chem. 270:7111-7116.
39. D. L. Dankort and W. J. Muller (2000). Signal transduction in mammary tumorigenesis: A transgenic perspective. Oncogene 19:1038-1044.
40. C. T. Guy, R. D. Cardiff, and W. J. Muller (1992). Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12:954-961.
41. M. A. Webster, J. N. Hutchinson, M. J. Rauh, S. K. Muthuswamy, M. Anton, C. G. Tortorice, R. D. Cardiff, F. L. Graham, J. A. Hassell, and W. J. Muller (1998). Requirement for both Shc and phosphatidylinositol 3′-kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol. Cell. Biol. 18:2344-2359.
42. R. Yao and G. M. Cooper (1995). Requirement for phosphatidylinositol 3-kinase in the prevention of apoptosis by nerve growth factor. Science 267:2003-2006.
43. S. R. Datta, A. Brunet, and M. E. Greenberg (1999). Cellular survival: A play in three Akts. Genes Dev. 13:2905-2927.
44. P. J. Coffer and J. R. Woodgett (1991). Molecular-cloning and characterization of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families. Eur. J. Biochem. 201:475-481.
45. P. F. Jones, T. Jakubowicz, F. J. Pitossi, F. Maurer, and B. A. Hemmings (1991). Molecular cloning and identification of a serine threonine protein-kinase of the 2nd-messenger subfamily. Proc. Natl. Acad. Sci. U.S.A. 89:9267-9271.
46. A. Bellacosa, J. R. Testa, S. P. Staal, and P. N. Tsichlis (1991). A retroviral oncogene Akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254:244-247.
47. A. Bellacosa, T. F. Franke, M. E. Gonzalez-Portal, K. Datta, T. Taguchi, J. Gardner, J. Q. Cheng, J. R. Testa, and P. N. Tsichlis (1993). Structure, expression and chromosomal mapping of c-akt: Relationship to v-akt and its implications. Oncogene 8:745-754.
48. T. F. Franke, S. I. Yang, T. O. Chan, K. Datta, A. Kazlauskas, D. K. Morrison, D. R. Kaplan, and P. N. Tsichlis (1995). The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81:727-736.
49. B. M. T. Burgering and P. J. Coffer (1995). Protein kinase B (c-Akt) in phosphatidylinositol 3-OH kinase signal-transduction. Nature 376:599-602.
50. T. F. Franke, D. R. Kaplan, L. C. Cantley, and A. Toker (1997). Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3, 4-bisphosphate. Science 275:665-668.
51. M. Frech, M. Andjelkovic, J. R. Falck, and B. A. Hemmings (1996). High affinity binding of inositol phosphates and phosphoinositides to the pleckstin-homology domain of RAC/protein kinase B and their influence on the kinase activity. J. Biol. Chem. 272:8474-8481.
52. A. Klippel, W. M. Kavanaugh, D. Pot, and L. T. Williams (1997). A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain. Mol. Cell. Biol. 17:338-344.
53. D. R. Alessi, M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, P. Cohen, and B. A. Hemmings (1996). Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15:6541-6551.
54. D. R. Alessi, S. R. James, C. P. Downes, A. B. Holmes, P. R. J. Gaffney, C. B. Reese, and P. Cohen (1997). Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα Curr. Biol. 7:261-269.
55. D. R. Alessi, M. Deak, A. Casamayor, F. B. Caudwell, N. Morrice, D. G. Norman, P. Gaffney, C. B. Reese, C. N. MacDougall, D. Harbison, A. Ashworth, and M. Bownes (1997). 3-phosphoinositide-dependent protein kinase-1 (PDK-1): Structural and functional homology with Drosophila DSTPK61 kinase. Curr. Biol. 7:776-789.
56. D. Stokoe, L. R. Stephens, T. Copeland, P. R. Gaffney, C. B. Reese, G. F. Painter, A. B. Holmes, F. McCormick, and P. T. Hawkins (1997). Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 277:567-570.
57. L. Stephens, K. Anderson, D. Stokoe, H. Erdjument-Bromage, G. F. Painter, A. B. Holmes, P. E. J. Gaffney, C. B. Reese, F. McCormick, P. Tempst, J. Coadwell, and P. T. Hawkins (1998). Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279:710-714.
58. N. Prasad, R. S. Topping, D. Zhou, and S. J. Decker (2000). Oxidative stress and vanadate induce tyrosine phosphorylation of phosphoinositide-dependent kinase 1. Biochemistry 39:6929-6935.
59. M. Delcommenne, C. Tan, V. Gray, L. Ruel, J. R. Woodgett, and S. Dedhar (1998). Phosphoinositide-3-OH kinase dependent regulation of glycogen synthase kinase-3 and protein kinase B/akt by the intergrin-linked kinase. Proc. Natl. Acad. Sci. U.S.A. 95:11211-11216.
60. S. Persad, S. Attwell, V. Gray, M. Delcommenne, A. Troussard, J. Sanghera, and S. Dedhar (2000). Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc. Natl. Acad. Sci. U.S.A. 97:3207-3212.
61. S. Dedhar (2000). Cell-substrate interactions and signaling through ILK. Curr. Opin. Cell Biol. 12:250-256.
62. D. K. Lynch, C. A. Ellis, P. A. Edwards and I. D. Hiles (1999). Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by and indirect mechanism. Oncogene 18:8024-8032.
63. A. Balendran, A. Casamayor, M. Deak, A. Paterson, P. Gaffney, R. Currie, C. P. Downes, and D. R. Alessi (1999). PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr. Biol. 9:393-404.
64. A. Toker and A. C. Newton (2000). Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J. Biol. Chem. 275:8271-8274.
65. B. Janji, C. Melchior, L. Vallar and N. Kieffer (2000). Cloning of an isoform of integrin-linked kinase (ILK) that is upregulated in HT-144 melanoma cells following TGF-β1 stimulation. Oncogene 19:3069-3077.
66. M. R. Williams, J. S. Arthur, A. Balendran, J. van der Kaay, V. Poli, P. Cohen, and D. R. Alessi (2000). The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr. Biol. 10:439-448.
67. S. Zimmermann and K. Moelling (1999). Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286:1741-1744.
68. H. Dudek, S. R. Datta, T. F. Franke, M. L. Birnbaum, R. J. Yao, G. M. Cooper, R. A. Segal, D. R. Kaplan, and M. E. Greenberg (1997). Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 278:661-665.
69. A. Kauffmann-Zeh, P. Rodriguez-Viciana, E. Ulrich, C. Golbert, P. Coffer, J. Downward, and G. Evan (1997). Suppression of c-Myc-induced apoptosis by Ras signaling through PI(3)K and PKB. Nature 385:544-548.
70. P. Hausler, G. Papoff, A. Eramo, K. Reif, D. A. Cantrell and G. Ruberti (1998). Protection of CD95-mediated apoptosis by activation of phosphatidylinositol 3-kinase and protein kinase B. Eur. J. Immunol. 28:57-69.
71. A. Khwaja, P. Rodriguez-Viciana, S. Wennstom, P. H. Warne, and J. Downward (1997). Matrix adhesion and Ras transformation both activate a phosphoinostide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 16:2783-2793.
72. P. Sabbatini and F. McCormick (1999). Phosphoinositide. 3-OH kinase (PI3K) and PKB/Akt delay the onset of p53-mediated, transcriptionally dependent apoptosis. J. Biol. Chem. 274:24263-24369.
73. J. Dahl, A. Jurczak, L. A. Cheng, D. C. Baker, and T. L. Benjamin (1998). Evidence for a role of phosphatidylinositol 3-kinase activation in the blocking of apoptosis by polyomavirus middle T antigen. J. Virol. 72:3221-3226.
74. B. E. Staveley, L. Ruel, J. Jin, V. Stambolic, F. G. Mastronardi, P Heitzler, J. R. Woodgett, and A. S. Manoukian (1998). Genetic analysis of protein kinase B (AKT) in Drosophila. Curr. Biol. 8:599-602.
75. A. Bergmann, J. Agapite, K. McCall, and H. Steller (1998). The Drosophila gene Hid is a direct molecular target of ras-dependent survival signaling. Cell 95:331-341.
76. H. Huang, C. J. Potter, W. Tao, D. M. Li, W. Brogiolo, E. Hafen, H. Sun, and T. Xu (1999). PTEN affects cell size, cell proliferation and apoptosis during Drosophila eye development. Development 126:5365-5372.
77. J. Verdu, M. A. Buratovich, E. L. Wilder, and M. J. Birnbaum (1999). Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB. Nat. Cell Biol. 1:500-506.
78. S. E. Scanga, L. Ruel, R. C. Binari, B. Snow, V. Stambolic, D. Bouchard, M. Peters, B. Calvieri, T. W. Mak, J. R. Woodgett, and A. S. Manoukian (2000). The conserved PI3′K/PTEN/Akt signaling pathway regulates both cell size and survival in Drosophila. Oncogene 19:3971-3977.
79. L levels in vivo. J. Exp. Med. 191:1721-1734.
80. E. C. Holland, J. Celestino, C. Dai, L. Schaefer, R. E. Sawaya, and G. N. Fuller (2000). Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet. 25:55-57.
81. H. Sun, R. Lesche, D. M. Li, J. Liliental, H. Zhang, J. Gao, N. Gavrilova, B. Mueller, X. Liu, and H. Wu (1999). PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc. Natl. Acad. Sci. U.S.A. 96:6199-6204.
82. S. Ramaswamy, N. Nakamura, F. Vazquez, D. B. Batt, S. Perera, T. M. Roberts, and W. R. Sellers (1999). Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. U.S.A. 96:2110-2115.
83. R. H. Medema, G. J. Kops, J. L. Bos, and B. M. Burgering (2000). AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404:782-787.
84. C. D. Helgason, J. E. Damen, P. Rosten, R. Grewal, P. Sorensen, S. M. Chappel, A. Borowski, F. Jirik, G. Krystal, and R. K. Humphries (1998). Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology and shortened lifespan. Genes. Dev. 12:1610-1620.
85. H. A. Lane, A. Fernandez, N. J. Lamb, and G. Thomas (1993). p70s6k function is essential for G1 progression. Nature 227:680-685.
86. H. B. J. Jefferies and G. Thomas (1996). Ribosomal protein S6 phosphorylation and signal transduction. In J. W. B. Hershey, and M. B. Mathews, N. Sonenbergm (eds.), Translational Control, Chap. 14, Cold Spring Harbor Laboratory Press, New York, pp. 389-409.
87. B. Cheatham, C. J. Vlahos, L. Cheatham, L. Wang, J. Blenis, and C. R. Kahn (1994). Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14:4902-4911.
88. J. Chung, T. C. Grammer, K. P. Lemon, A. Kazlauskas, and J. Blenis (1994). PDGF- and insulin-dependent pp70 S6k activation mediated by phosphatidylinositol 3-OH kinase. Nature 370:71-75.
89. X. F. Ming, B. M. Burgering, S. Wennstrom, L. Claesson-Welsh, C. H. Heldin, J. L. Bos, S. C. Kozma, and G. Thomas (1994). Activation of p70/p85 S6 kinase by a pathway independent of p21ras. Nature 371:426-429.
90. N. Pullen and G. Thomas (1997). The modular phosphorylation and activation of p70s6k. FEBS Lett. 410:78-82.
91. A. Balendran, R. Currie, C. G. Armstrong, J. Avruch, and D. R. Alessi (1999). Evidence that 3-phosphoinositide-dependent protein kinase-1 mediates phosphorylation of p70 S6 kinase in vivo at Thr-412 as well as Thr-252. J. Biol. Chem. 274:37400-37406.
92. N. Pullen, P. B. Dennis, M. Andjelkovic, A. Dufner, S. C. Kozma, B. A. Hemmings, and G. Thomas (1998). Phosphorylation and activation of p70S6k by PDK1. Science 279:707-710.
93. D. R. Alessi, M. T. Kozlowski, Q. P. Weng, N. Morrice, and J. Avruch (1998). 3-phosphoinositide dependent protein kinase 1 (PDK2) phosphorylates and activates the p70S6 kinase in vivo and in vitro. Curr. Biol. 8:69-81.
94. J. Chung, C. J. Kuo, G. R. Crabtree, and J. Blenis (1992). Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell 69:1227-1236.
95. P. B. Dennis, N. Pullen, S. C. Kozma, and G. Thomas (1996). The principle rapamycin-sensitive p70S6k phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases. Mol. Cell. Biol. 16:6242-6251.
96. M. P. Scheid, L. Charlton, S. L. Pelech, and V. Duronio (1996). Role of p70 S6 kinase in inhibition of cell death by cytokines. Biochem. Cell Biol. 74:595-600.
97. R. Yao and G. M. Cooper (1996). Growth factor-dependent survival of rodent fibroblasts requires phosphatidylinositol 3-kinase but is independent of pp70S6K activity. Oncogene 13:343-351.
98. S. Ogg, S. Paradis, S. Gottlieb, G. I. Patterson, L. Lee, H. A. Tissenbaum, and G. Ruvkun (1997). The Forkhead transcription factor Daf-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389:994-999.
99. S. Paradis and G. Ruvkun (1998). Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the Daf-16. Genes Dev. 12:2488-2498.
100. A. Brunet, A. Bonni, M. J. Zigmond, M. Z. Lin, P. Juo, L. S. Hu, M. J. Anderson, K. C. Arden, J. Blenis, and M. E. Greenberg (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868.
101. W. H. Biggs, 3rd, J. Meisenhelder, T. Hunter, W. K. Cavenee, and K. C. Arden (1999). Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl. Acad. Sci. U.S.A. 96:7421-7426.
102. G. J. Kops, N. D. de Ruiter, A. M. De Vries-Smits, D. R. Powell, J. L. Bos, and B. M. Burgering (1999). Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398:630-634.
103. F. Mercurio and A. M. Manning (1999). NF-κB as a primary regulator of the stress response. Oncogene 18:6163-6171.
104. L. P. Kane, V. S. Shapiro, D. Stokoe, and A. Weiss (1999). Induction of NF-κB by the Akt/PKB kinase. Curr. Biol. 9:601-604.
105. J. A. Romashkova and S. S. Makarov (1999). NF-κB is a target of AKT in anti-apoptotic PDGF signaling. Nature 401:86-90.
106. O. N. Ozes, L. D. Mayo, J. A. Gustin, S. R. Pfeffer, L. M. Pfeffer, and D B. Donner (1999). NF-κB activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature 401:82-85.
107. N. Sizemore, S. Leung, and G. R. Stark (1999). Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-κB p65/Re1A subunit. Mol. Cell. Biol. 19:4798-4805.
108. L. V. Madrid, C. Y. Wang, D. C. Guttridge, A. J. Schottelius, A. S. Baldwin, Jr., and M. W. Mayo (2000). Akt suppresses apoptosis by stimulating the transactivation potential of the Re1A/p65 subunit of NF-κB. Mol. Cell Biol. 20:1626-1638.
109. M. P. Scheid and J. R. Woodgett (2000). Protein kinases: Six degrees of separation? Curr. Biol. 10:R191-R194.
110. X. He, J. P. Saint-Jeannet, J. R. Woodgett, H. E. Varmus, and I. B. Dawid (1995). Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos. Nature 374:617-622.
111. S. Ikeda, S. Kishida, H. Yamamoto, H. Murai, S. Koyama, and A. Kikuchi (1998). Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J. 17:1371-1384.
112. G. I. Welsh, C. Wilson, and C. G. Proud (1996). GSK3: A SHAGGY frog story. Trends Cell Biol. 6:274-279.
113. W. B. Boyle, T. Smeal, L. H. K. Defize, P. Angel, J. R. Woodgett, M. Karin, and T. Hunter (1991). Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA binding activity. Cell 64:573-584.
114. C. R. Beals, C. M. Sheridan, C. W. Turck, P. Gardner, and G. R. Crabtree (1997). Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275:1930-1932.
115. J. A. Diehl, M. Cheng, M. F. Roussel, and C. J. Sherr (1999). Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12:3499-3511.
116. D. A. E. Cross, D. R. Alessi, J. R. Vandenheede, H. E. McDowell, H. S. Hundal, and P. Cohen (1994). The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: Evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem. J. 303:21-26.
117. D. A. E. Cross, D. R. Alessi, P. Cohen, M. Andjelkovich, and B. A. Hemmings (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789.
118. K. P. Hoeflich, J. Luo, E. A. Rubie, M. S. Tsao, O. Jin, and J. R. Woodgett (2000). Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation. Nature 406:86-90.
119. L, and Bcl-2, displaces Bax and promotes cell death. Cell 80:285-291.
120. L. Cell 87:619-628.
121. S. R. Datta, H. Dudek, X. Tao, S. Masters, H. A. Fu, Y. Gotoh, and M. E. Greenburg (1997). Akt phosphorylation of Bad couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241.
122. L. del Peso, M. Gonzalez-Garcia, C. Page, R. Herrera, and G. Nunez (1997). Interleukin-3-induced phosphorylation of Bad through the protein kinase Akt. Science 278:687-689.
123. P. Blume-Jensen, R. Janknecht, and T. Hunter (1998). The c-kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136. Curr. Biol. 8:779-782.
124. J. Gu, M. Tamura, and K. M. Yamada (1998). Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J. Cell Biol. 143:1375-1383.
125. C. D. Helgason, C. P. Kalberer, J. E. Damen, S. M. Chappel, N. Pineault, G. Krystal, and R. K. Humphries (2000). A dual role for Src homology 2 domain-containing inositol-5-phosphatase (SHIP) in immunity: Aberrant development and enhanced function of b lymphocytes in ship -/- mice. J. Exp. Med. 191:781-794.
126. A. Bonni, A. Brunet, A. E. West, S. R. Datta, M. A. Takasu, and M. E. Greenberg (1999). Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286:1358-1362.
127. X. Fang, S. Yu, A. Eder, M. Mao, R. C. Bast Jr, D. Boyd, and G. B. Mills (1999). Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway. Oncogene 18:6635-6640.
128. L by the MAPK/Erk kinase. J. Biol. Chem. 274:31108-31113.
129. A. Shimamura, B. A. Ballif, S. A. Richards, and J. Blenis (2000). Rsk1 mediates a MEK-MAP kinase cell survival signal. Curr. Biol. 10:127-135.
130. L interaction and cell survival. J. Biol. Chem. (in press).
131. M. P. Scheid and V. Duronio (1998). Dissociation of cytokine induced phosphorylation of Bad and activation of PKB/Akt. Involvement of MEK upstream of Bad phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 95:7439-7444.
132. D. W. Nicholson (1999). Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6:1028-1042.
133. M. H. Cardone, N. Roy, H. R. Stennicke, G. S. Salvensen, T. F. Franke, E. Stanbridge, S. Frisch, and J. C. Reed (1998). Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318-1321.
134. J. Rodriguez, H. H. Chen, S. C. Lin, and Y. Lazebnik (2000). Caspase phosphorylation, cell death, and species variability. Science 287:1363a.
135. J. C. Reed, M. H. Cardone, N. Roy, H. R. Stennicke, G. S. Salvesen, T. F. Franke, and R. Stanbridge (2000). Caspase phosphorylation, cell death, and species variability. Science 287:1363a.
136. H. W. Chang, M. Aoki, D. Fruman, K. R. Auger, A. Bellacosa, P. N. Tsichlis, L. C. Cantley, T. M. Roberts, and P. K. Vogt (1997). Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science 276:1848-1850.
137. L. Shayesteh, Y. Lu, W. L. Kuo, R. Baldocchi, T. Godfrey, C. Collins, D. Pinkel, B. Powell, G. B. Mills, and J. W. Gray (1999). PIK3CA is implicated as an oncogene in ovarian cancer. Nat. Genet. 21:99-102.
138. J. Q. Cheng, A. K. Godwin, A. Bellacosa, T. Taguchi, T. F. Franke, T. C. Hamilton, P. N. Tsichlis, and J. R. Testa (1992). AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc. Natl. Acad. Sci. U.S.A. 89:9267-9271.
139. J. Q. Cheng, B. Ruggeri, W. M. Klein, G. Sonoda, D. A. Altomare, D. K. Watson, and J. R. Testa (1996). Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc. Natl. Acad. Sci. U.S.A. 93:3636-3641.
140. A. Bellacosa, D. de Feo, A. K. Godwin, D. W. Bell, J. Q. Cheng, D. A. Altomare, M. Wan, L. Dubeau, G. Scambia, V. Masciullo et al. (1995). Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int. J. Cancer 64:280-285.
141. C. Wu, S. Y. Keightley, C. Leung-Hagesteijn, G. Radeva, M. Coppolino, S. Goicoechea, J. A. McDonald, and S. Dedhar (1998). Integrin-linked protein kinase regulates fibronectin matrix assembly, E-cadherin expression, and tumorigenicity. J. Biol. Chem. 273:528-536.
142. J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose, S. I. Wang, J. Pue, C. Miliaresis, L. Rodgers, R. McCombie, S. H. Bigner, B. C. Giovanella, M. Ittmann, B. Tycko, H. Hibshoosh, M. H. Wigler, and R. Parsons (1997). PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943-1947.
143. P. A. Steck, M. A. Pershouse, S. A. Jasser, W. K. Yung, H. Lin, A. H. Ligon, L. A. Langford, M. L. Baumgard, T. Hattier, T. Davis, C. Frye, R. Hu, B. Swedlund, D. H. Teng, and S. V. Tavtigian (1997). Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23. 3 that is mutated in multiple advanced cancers. Nat. Genet. 15:356-362.
144. J. Bostrom, J. M. Cobbers, M. Wolter, G. Tabatabai, R. G. Weber, P. Lichter, V. P. Collins, and G. Reifenberger (1998). Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Cancer Res. 58:29-33.
145. W. Liu, C. D. James, L. Frederick, B. E. Alderete, and R. B. Jenkins (1997). PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res. 57:5254-5257.
146. B. K. Rasheed, T. T. Stenzel, R. E. McLendon, R. Parsons, A. H. Friedman, H. S. Friedman, D. D. Bigner, and S. H. Bigner (1997). PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res. 57:4187-4190.
147. S. I. Wang, J. Pue, J. Li, J. N. Bruce, P. Cairns, D. Sidransky, and R. Parsons (1997). Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res. 57:4183-4186.
148. P. Cairns, K. Okami, S. Halachmi, N. Halachmi, M. Esteller, J. G. Herman, J. Jen, W. B. Isaacs, G. S. Bova, and D. Sidransky (1997). Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res. 57:4997-5000.
149. D. H. Teng, R. Hu, H. Lin, T. Davis, D. Iliev, C. Frye, B. Swedlund, K. L. Hansen, V. L. Vinson, K. L. Gumpper, L. Ellis, A. El-Naggar, M. Frazier, S. Jasser, L. A. Langford, J. Lee, G. B. Mills, M. A. Pershouse, R. E. Pollack, C. Tornos, P. Troncoso, W. K. Yung, G. Fujii, A. Berson, R. Bookstein, J. B. Bolen, S. V. Tavtigian, and P. A. Steck (1997). MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res. 57:5221-5225.
150. J. I. Risinger, A. K. Hayes, A. Berchuck, and J. C. Barrett (1997). PTEN/MMAC1 mutations in endometrial cancers Cancer Res. 57:4736-4738.
151. H. Tashiro, M. S. Blazes, R. Wu, K. R. Cho, S. Bose, S. I. Wang, J. Li, R. Parsons, and L. H. Ellenson (1997). Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res. 57:3935-3940.
152. J. I. Risinger, K. Hayes, G. L. Maxwell, M. E. Carney, R. K. Dodge, J. C. Barrett, and A. Berchuck (1998). PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics. Clin. Cancer Res. 4:3005-3010.
153. D. Liaw, D. J. Marsh, J. Li, P. L. Dahia, S. I. Wang, Z. Zheng, S. Bose, K. M. Call, H. C. Tsou, M. Peacocke, C. Eng, and R. Parsons (1997). Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 16:64-67.
154. D. J. Marsh, V. Coulon, K. L. Lunetta, P. Rocca-Serra, P. L. Dahia, Z. Zheng, D. Liaw, S. Caron, B. Duboue, A. Y. Lin, A. L. Richardson, J. M. Bonnetblanc, J. M. Bressieux, A. Cabarrot-Moreau, A. Chompret, L. Demange, R. A. Eeles, A. M. Yahanda, E. R. Fearon, J. P. Fricker, R. J. Gorlin, S. V. Hodgson, S. Huson, and D. Lacombe (1998). Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Human Mol. Genet. 7:507-515.
155. D. J. Marsh, P. L. Dahia, S. Caron, J. B. Kum, I. M. Frayling, I. P. Tomlinson, K. S. Hughes, R. A. Eeles, S. V. Hodgson, V. A. Murday, R. Houlston, and C. Eng (1998). Germline PTEN mutations in Cowden syndrome-like families. J. Med. Genet. 35:881-885.
156. D. J. Marsh, P. L. Dahia, Z. Zheng, D. Liaw, R. Parsons, R. J. Gorlin, and C. Eng (1997). Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet. 16:333-334.
157. C. M. Perou, T. Sorlie, M. B. Eisen, M. van de Rijn, S. S. Jeffrey, C. A. Rees, J. R. Pollack, D. T. Ross, H. Johnsen, L. A. Akslen, O. Fluge, A. Pergamenschikov, C. Williams, S. X. Zhu, P. E. Lonning, A. L. Borresen-Dale, P. O. Brown, D. Botstein, (2000). Molecular portraits of human breast tumors. Nature 406:747-752.